IVBH
IVBH is a healthcare diagnostics company pioneering early detection of disease at stage zero by analyzing the patient's dynamic genomic response through changes in RNA gene expression. The company develops internally designed blood tests that integrate seamlessly into existing care pathways, focusing on improving physical, mental, emotional, and financial health outcomes. IVBH's business model emphasizes speed, efficiency, risk mitigation, and the use of AI throughout the diagnostic development process. Their platform is disease-agnostic and scalable, aiming to maximize social impact and financial results by bringing precision health solutions to the masses. Key products include blood tests for women's health (mammogen), lung health (liquidlung), and metabolic health (hepgene). The company is headquartered in Newport Beach, CA, and led by founder Marty Keiser.
IVBH
IVBH is a healthcare diagnostics company pioneering early detection of disease at stage zero by analyzing the patient's dynamic genomic response through changes in RNA gene expression. The company develops internally designed blood tests that integrate seamlessly into existing care pathways, focusing on improving physical, mental, emotional, and financial health outcomes. IVBH's business model emphasizes speed, efficiency, risk mitigation, and the use of AI throughout the diagnostic development process. Their platform is disease-agnostic and scalable, aiming to maximize social impact and financial results by bringing precision health solutions to the masses. Key products include blood tests for women's health (mammogen), lung health (liquidlung), and metabolic health (hepgene). The company is headquartered in Newport Beach, CA, and led by founder Marty Keiser.